Premium
AbCellera Biologics Inc (ABCL)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners. AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the following investor conferences: Piper Sandler 36th Annual Healthcare Conference in New York, NY on...
AbCellera (Nasdaq: ABCL) today announced new data on its T-cell engager (TCE) platform, to be presented as a poster at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting at the...
AbCellera (Nasdaq: ABCL) today announced financial results for the third quarter of 2024. All financial information in this press release is reported in U.S. dollars, unless otherwise...
AbCellera (Nasdaq: ABCL) today announced that executives from the Company will be presenting at the following investor conferences: Stifel Healthcare Conference on Monday, November 18, 2024, at...
AbCellera (Nasdaq: ABCL) today announced an upcoming poster presentation on its T-cell engager platform at the SITC 39th Annual Meeting, to be held November 6 to 10 at the George R. Brown...
AbCellera (Nasdaq: ABCL) will announce its third quarter 2024 financial results on Monday, November 4, 2024, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.23 | -7.59075907591 | 3.03 | 3.05 | 2.62 | 3025429 | 2.76573612 | CS |
| 4 | 0.06 | 2.1897810219 | 2.74 | 3.09 | 2.62 | 2595848 | 2.88622818 | CS |
| 12 | 0.2 | 7.69230769231 | 2.6 | 3.18 | 2.41 | 2297637 | 2.802675 | CS |
| 26 | -0.16 | -5.40540540541 | 2.96 | 3.6 | 2.335 | 2080972 | 2.77401386 | CS |
| 52 | -2.83 | -50.2664298401 | 5.63 | 6.055 | 2.335 | 1749081 | 3.48667681 | CS |
| 156 | -11.78 | -80.7956104252 | 14.58 | 15.9 | 2.335 | 1964265 | 7.0654954 | CS |
| 260 | -58.2 | -95.4098360656 | 61 | 71.91 | 2.335 | 1899987 | 10.83880274 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
